Portsmouth Technologies Sells 30 Lakh Anthem Biosciences Shares Worth Rs 250 Crore
Portsmouth Technologies LLC sold 30 lakh shares of Anthem Biosciences at Rs 833 each on October 9, totaling approximately Rs 250 crore, reducing its stake from 2.73% to an estimated 2.2%. Anthem Biosciences reported a 21.3% decline in total income and an 11.7% drop in profit after tax for Q1 FY27. Shares closed lower after the sale, trading below the block deal price. The buyer's identity was not disclosed, and the company's market capitalization stood at around Rs 48,539 crore.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (49/100). Lens Score 45/100.
Outlets measured: moneycontrol, economictimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (48–50/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 9 Oct, 04:28 pm. Other outlets followed.